Use of Tegwondo, a near-continuous temozolomide regimen, in high- and low-grade gliomas.

被引：1
|
作者：
Strik, H. M.
Bock, H. C.
Marosi, C.
机构：
[1] Univ Marburg, Marburg, Germany
[2] Univ Gottingen, D-37073 Gottingen, Germany
[3] Med Univ Vienna, Dept Med 1, Div Clin Oncol, Vienna, Austria
[4] Med Univ Vienna, Ctr Comprehens Canc, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.2084
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2084
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tegwondo-CCNU: A novel combination of protracted, near-continuous temozolomide and CCNU with activity in recurrent malignant gliomas.
    Strik, Herwig Matthias
    Rock, Hans
    Kallenberg, Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] TEGWONDO-DEVELOPMENT OF A NOVEL NEAR-CONTINUOUS DOSE-DENSE TEMOZOLOMIDE REGIMEN FOR THE TREATMENT OF RECURRENT GLIOMAS
    Strik, H. M.
    Buhk, J. H.
    Bock, C.
    Nitsche, M.
    Hoffmann, A. L.
    Wrede, A.
    Marosi, C.
    Kaiser, U.
    Christmann, M.
    Kaina, B.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1062 - 1062
  • [3] SAFETY AND EFFICACY OF NEAR-CONTINUOUS DOSE-DENSE TEMOZOLOMIDE (TEGWONDO) FOR RECURRENT GLIOMAS
    Strik, Herwig
    Buhk, Jan H.
    Bock, Christoph-H.
    Wrede, Arne
    Marosi, Christine
    Kaiser, Ulrich
    Christmann, Markus
    Kaina, Bernd
    NEURO-ONCOLOGY, 2009, 11 (06) : 947 - 947
  • [4] TEGWONDO-CCNU - A NOVEL COMBINATION OF PROTRACTED, NEAR-CONTINUOUS TEMOZOLOMIDE AND CCNU WITH ACTIVITY IN RECURRENT MALIGNANT GLIOMAS
    Strik, H. M.
    Carl, B.
    Kallenberg, K.
    NEURO-ONCOLOGY, 2012, 14 : 43 - 43
  • [5] Tegwondo: Development of a novel near-continuous dose-dense temozolomide regimen for the treatment of recurrent brain tumors
    Strik, H. M.
    Buhk, J. H.
    Bock, C.
    Hoffmann, A. L.
    Wrede, A.
    Marosi, C.
    Kaiser, U.
    Christmann, M.
    Kaina, B.
    Baehr, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] INCIDENCE OF NEUROPSYCHOLOGICAL DISTURBANCES IN LOW-GRADE GLIOMAS.
    Zucchella, C.
    Villani, V.
    Benincasa, D.
    Scicchitano, S.
    Guariglia, L.
    Ieraci, S.
    Pace, A.
    NEURO-ONCOLOGY, 2016, 18 : 23 - 23
  • [7] NEAR-CONTINUOUS TEMOZOLOMIDE AND LOW-DOSE WEEKLY CCNU: A NOVEL CHEMOTHERAPY REGIMEN WITH ACTIVITY IN MALIGNANT GLIOMAS RESISTANT TO DOSE-DENSE TEMOZOLOMIDE ALONE
    Strik, H. M.
    Bock, H. C.
    Kallenberg, K.
    NEURO-ONCOLOGY, 2010, 12 : 46 - 46
  • [8] A neurosurgeon's perspective on the neuropathology of low-grade gliomas.
    Piepmeier J.M.
    Brain Tumor Pathology, 2000, 17 (2) : 85 - 88
  • [9] Near-continuous temozolomide and low-dose weekly CCNU: A novel chemotherapy regimen with activity in malignant gliomas resistant to dose-dense temozolomide alone.
    Strik, H. M.
    Bock, C. H.
    Kallenberg, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Temozolomide and radiation in low-grade and anaplastic gliomas: Temoradiation
    Schiff, David
    CANCER INVESTIGATION, 2007, 25 (08) : 776 - 784
12345